Precigen (PGEN) EBIT (2012 - 2026)
Precigen's (PGEN) quarterly EBIT came in at -$6.0 million in Q1 2026, up 73.47% year-on-year from -$3.5 million in Q1 2025, and up 72.33% on a QoQ basis from -$21.7 million in Q4 2025.
Precigen (PGEN) EBIT (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of EBIT data on file, last reported at -$6.0 million in Q1 2026.
- On a quarterly basis, EBIT rose 73.47% year-over-year to -$6.0 million in Q1 2026; TTM through Mar 2026 was -$93.9 million, a 29.51% increase from a year earlier, with the FY2025 full-year figure at -$110.5 million, up 18.16% from the prior year.
- EBIT for Q1 2026 stood at -$6.0 million, up from -$21.7 million in the prior quarter.
- Over the last five years, EBIT for PGEN reached as high as -$6.0 million in Q1 2026 and fell as low as -$60.8 million in Q2 2024.
- Historically, EBIT has averaged -$25.1 million across 5 years, with a median of -$22.6 million in 2025.
- Across the five-year window, EBIT slumped 188.07% in 2024 and jumped 73.47% in 2026, its largest moves.
- Year by year, EBIT stood at -$21.8 million in 2022, then sank by 57.01% to -$34.2 million in 2023, then advanced by 16.68% to -$28.5 million in 2024, then grew by 24.02% to -$21.7 million in 2025, then surged by 72.33% to -$6.0 million in 2026.
- Per Business Quant data, the three most recent EBIT figures were -$6.0 million in Q1 2026, -$21.7 million in Q4 2025, and -$34.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | -5.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.99 Mn |
| Dec 31, 2025 | -21.67 Mn |
| Sep 30, 2025 | -34.48 Mn |
| Jun 30, 2025 | -31.76 Mn |
| Mar 31, 2025 | -22.60 Mn |
| Dec 31, 2024 | -28.52 Mn |
| Sep 30, 2024 | -21.26 Mn |
| Jun 30, 2024 | -60.84 Mn |
| Mar 31, 2024 | -24.41 Mn |
| Dec 31, 2023 | -34.22 Mn |
| Sep 30, 2023 | -20.94 Mn |
| Jun 30, 2023 | -21.12 Mn |
| Mar 31, 2023 | -23.48 Mn |
| Dec 31, 2022 | -21.80 Mn |
| Sep 30, 2022 | -7.61 Mn |
| Jun 30, 2022 | -24.16 Mn |
| Mar 31, 2022 | -22.15 Mn |
| Dec 31, 2021 | -21.87 Mn |
| Sep 30, 2021 | -21.53 Mn |
| Jun 30, 2021 | -26.22 Mn |